ClickHouse Raises $350 Million Series C to Power Analytics for the AI Era
ClickHouse, Inc., a leader in real-time analytics, data warehousing, observability, and AI/ML, today announced it has raised $350 million in Series C financing. The round was led by Khosla Ventures, with participation from new investors BOND, IVP, Battery Ventures, and Bessemer Venture Partners, as well as existing investors including Index Ventures, Lightspeed, GIC, Benchmark, Coatue, FirstMark, and Nebius. Today’s round follows earlier investments of over $300 million, bringing total funding to over $650 million.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529254399/en/
The ClickHouse Founders - Aaron Katz, Yury Izrailevsky, Alexey Milovidov
This combined funding will be used to scale product development, support global expansion, and deepen partnerships with customers and technology providers building the next wave of AI-native applications. In addition to this financing, ClickHouse has secured a $100 million credit facility led by Stifel and Goldman Sachs.
The momentum behind ClickHouse is accelerating: the company grew over 300% during the past year and now serves over 2,000 customers across a range of industries from fintech and transportation to consumer and healthcare. New customers include Anthropic, Tesla, and Argentina’s Mercado Libre, among others. They join companies such as Sony, Meta, Memorial Sloan Kettering, Lyft, and Instacart, as well as AI innovators Sierra, Poolside, Weights & Bases, Langchain, and more.
Today’s announcement was made at ClickHouse’s inaugural user conference, showcasing how enterprises are building data products to meet the demands of the agentic era.
“As AI agents proliferate across data-driven applications, observability, data infrastructure, and beyond, the demand for agent-facing databases like ClickHouse has reached an inflection point. The future of analytics isn’t just dashboards. It’s intelligent agents that interpret data, trigger workflows, and power real-time decisions,” said Aaron Katz, CEO of ClickHouse. “But AI is just one driver. We designed and built ClickHouse from day one to support a broad spectrum of real-time data applications across industries, and our momentum reflects that enterprises are hungry for a platform that can keep up with their scaling ambitions.”
“We invested in ClickHouse because they’re solving one of the most important infrastructure challenges of this era of AI and agents: enabling real-time data platforms that can support both traditional analytics and the growing demands of AI-native workloads,” said Ethan Choi, Partner at Khosla Ventures. “As AI reshapes every industry, the ability to deliver fast, scalable, and cost-efficient analytics is becoming foundational, ClickHouse is poised to become the default engine for next-generation intelligent data products.”
The Next Frontier: Real-Time Analytics for Agentic Workloads
The market traction around ClickHouse is rooted in a fundamental shift: enterprises are no longer just building dashboards or batch reports—they are building real-time, intelligent data platforms that must serve both human and AI agents. Since AI agents can generate queries much faster and at a higher rate than human analysts, agent-facing databases must support low-latency, interactive analytical queries at an increasingly high throughput.
ClickHouse was designed from the ground up to meet this demand. Its high-performance, columnar storage engine enables interactive, analytical queries across massive datasets with minimal latency—perfect for powering AI and ML applications, real-time analytics, cloud data warehousing, and observability workloads.
Built for Speed at Scale: High-Performance Analytics Across Industries
Traditional databases and warehouses are struggling to keep up with this demand. Transactional databases don’t scale for analytical workloads. Meanwhile, traditional data warehouses are optimized for internal, batch-heavy use cases with limited concurrency and slow performance. Finally, search-oriented technologies become prohibitively expensive for structured analytics—using 10x more in storage and compute and limiting the practical range of applications due to cost.
By contrast, ClickHouse offers a purpose-built solution that bridges the gap—combining high-performance analytics with the scalability and concurrency that today’s intelligent, data-driven applications require.
About ClickHouse
ClickHouse is a fast, open-source columnar database management system built for real-time data processing and analytics at scale. Engineered for high performance, ClickHouse Cloud delivers exceptional query speed and concurrency, making it ideal for applications that demand instant insight from massive volumes of data. As AI agents become increasingly embedded in software and are generating far more frequent and complex queries, ClickHouse brings a high-throughput, low-latency engine, purpose-built to meet this challenge. Trusted by leading companies like Sony, Tesla, Anthropic, Memorial Sloan Kettering, Lyft, and Instacart, ClickHouse helps teams unlock insights and drive smarter decisions with a scalable, efficient, and modern data platform. For more information, visit clickhouse.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250529254399/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
BeOne Medicines Presents New SEQUOIA Study Results Reinforcing BRUKINSA’s Differentiated Profile with or without Venetoclax in Frontline CLL at ASCO 202531.5.2025 14:00:00 CEST | Press release
BRUKINSA plus venetoclax demonstrated high response rates and a favorable safety profile across CLL patient types in SEQUOIA Arm D, including those with high-risk del(17p) mutational statusAt 5-year follow-up of SEQUOIA Arm C, BRUKINSA monotherapy showed sustained OS and PFS benefit in hard-to-treat del(17p) CLL patients versus historical data BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today will present new data from the Arm C and D cohorts of the pivotal, global Phase 3 SEQUOIA trial of BRUKINSA® (zanubrutinib). The findings underscore the strong and consistent efficacy of BRUKINSA across CLL patient types, including high-risk mutation status. These data will be presented in two rapid oral presentations at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, IL. Data from the Arm D of SEQUOIA demonstrate that treatment with BRUKINSA plus venetoclax has the potential to drive progression-free survival and overall dee
Andersen Consulting tilføjer Stratence Partners30.5.2025 16:07:00 CEST | Pressemeddelelse
Andersen Consulting udvider sin platform med en samarbejdsaftale med Stratence Partners, der er et konsulentfirma med base i Storbritannien, som hjælper globale virksomheder med at øge markedsandele og forbedre rentabiliteten gennem deres ekspertise inden for prisfastsættelse, strategisk optimering, kommerciel effektivitet og digital transformation. Stratence Partners har en resultatorienteret tilgang og er forpligtet på bæredygtig forandring, hvorved de hjælper deres kunder gennem en unik kombination af konsulentbistand, midlertidige ledelsesindsater og oplæringskurser samt deres egne metoder og løsninger inden for datastyring, datavidenskab (AI), værktøjer og systemer. "Samarbejdet med Andersen Consulting er et spændende skridt for vores firma," sagde Fernando Ventureira, administrerende direktør for Stratence Partners. "I vores arbejde med hos ledere over hele verden har vi erfaret, at deres behov rækker ud over strategisk prisfastsættelse og driftsoptimering. Vores kunder værdsætte
You Up? Grindr’s “Right Now” Goes Global30.5.2025 15:00:00 CEST | Press release
More places, more people – Grindr’s real-time hookup feature makes connecting faster than ever Grindr, the Global Gayborhood in Your Pocket™ with more than 14.6M average monthly active users, today announced the global launch of Right Now, their newest intent-based feature designed to instantly connect people looking for immediate encounters. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250530651954/en/ Grindr's Right Now feature. Right Now is a real-time feed—separate from the app’s main grid that displays profiles—where Grindr users can post text and share photos displayed for one hour, letting other like-minded users know exactly what they’re looking for. “Right Now empowers our users to find exactly what they want, when they want it – without the guesswork,” said AJ Balance, Chief Product Officer at Grindr. “We built this intention-based feature based on feedback from our community so they can connect with like-minded
CAR T Vision Coalition Launches with Ambitious Goal to Double Patients Treated with the Curative Potential of CAR T-cell Therapy by 203030.5.2025 14:00:00 CEST | Press release
Only approximately 2 out of 10 people in the US and 3 out of 10 people in Europe with certain rare, advanced blood cancers receive access to CAR T-cell therapy1,2,3New roadmap report aims to inspire collective action of stakeholder groups and invites additional CAR T-cell therapy leaders to join the coalition Today an international coalition announces the launch of CAR T Vision to unite stakeholders around the shared ambition that every eligible patient should have the opportunity for cure with CAR T-cell therapy. By 2030, the aim is to double the proportion of eligible patients treated with CAR T-cell therapy. As outlined in the new roadmap report, the coalition will work to address access challenges and drive meaningful change in the CAR T-cell therapy healthcare ecosystem with a focus on three critical priorities: increasing awareness and understanding of CAR T-cell therapy; expanding resources and capacity to deliver CAR T-cell therapy; and developing sustainable and innovative fin
Indian Educationist Dr. Achyuta Samanta Recognised With Research Institute in His Name at CUNY, USA30.5.2025 11:17:00 CEST | Press release
In a noteworthy development underscoring growing academic collaboration between India and the United States, the City University of New York (CUNY) has launched a dedicated research platform—the Achyuta Samanta India Initiative of the CUNY CREST Institute (ASIICCI). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250529012005/en/ Dr. Milton Santiago, President of Bronx Community College, and Dr. Achyuta Samanta, Founder of KIIT & KISS, jointly inaugurate the Achyuta Samanta India Initiative of CUNY CREST Institute (ASIICCI) with a ribbon-cutting ceremony in New York. Named after Dr. Achyuta Samanta, a noted Indian educationist and social worker, the initiative focuses on academic research in Indian social and educational sectors, with a particular lens on Odisha. This marks one of the rare instances of a living Indian being honoured with such a naming in an American public university system. Dr. Samanta, who hails from Odisha
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom